Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Debbie Hicks

Newcastle AuthorsTitleYearFull text
Professor Steven Clifford
Dr Ed Schwalbe
Dr Debbie Hicks
Imaging Characteristics of Wingless Pathway Subgroup Medulloblastomas: Results from the German HIT/SIOP-Trial Cohort2019
Dr Ed Schwalbe
Dr Daniel Williamson
Dr Janet Lindsey
Dr Rebecca Hill
Dr Debbie Hicks
et al.		Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes2019
Dr Ed Schwalbe
Dr Debbie Hicks
Professor Steven Clifford
Prognostic impact of whole chromosomal 1 aberration signatures in standard-risk non-WNT/non-SHH medulloblastoma: a retrospective molecular analysis of the HIT-SIOP-PNET4 clinical trial2018
Professor Steven Clifford
Dr Debbie Hicks
Dr Janet Lindsey
Dr Rebecca Hill
Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours2017
Dr Lizzie Harris
Dr Ana Topf
Dr Rita Barresi
Dr Debbie Hicks
Dr Anna Porter
et al.		Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy2017
Dr Ed Schwalbe
Dr Debbie Hicks
Dr Reza Rafiee
Dr Matthew Bashton
Dr Amir Enshaei
et al.		Minimal methylation classifier (MIMIC): A novel method for derivation and rapid diagnostic detection of disease-associated DNA methylation signatures2017
Dr Ed Schwalbe
Dr Janet Lindsey
Dr Sirintra Nakjang
Dr Stephen Crosier
Amanda Smith
et al.		Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study2017
Dr Stephen Crosier
Dr Debbie Hicks
Dr Ed Schwalbe
Dr Daniel Williamson
Sarah Nicholson
et al.		Centralised Molecular Pathology for Rare Tumours: A National Feasibility Study of Real-Time Medulloblastoma Diagnostics2016
Professor Steven Clifford
Dr Stephen Crosier
Dr Debbie Hicks
Stewart Nicholson
Dr Nicholas Bown
et al.		Establishment of national real-time central pathology review (CPR) and molecular diagnostics for medulloblastoma (MB)2016
Dr Ed Schwalbe
Dr Debbie Hicks
Professor Steven Clifford
Health-Related Quality of Life (HRQoL) in HIT-SIOP-PNET4 trial survivors: differences between medulloblastoma molecular subgroups2016
123456